Trial site
Grayline Research Center
- 8running trials
- 13closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Depression12 trials
- Alzheimer disease4 trials
- Bipolar disorder2 trials
- Insomnia1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 211 trials
- Phase 39 trials
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Xenon Pharmaceuticals Inc.4 trials
- Biohaven Therapeutics Ltd.2 trials
- Boehringer Ingelheim2 trials
- Cassava Sciences, Inc.2 trials
- Engrail Therapeutics INC2 trials
- and 8 more
Running trials
Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
Active, not recruiting
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Active, not recruiting
Active, not recruiting
An Open-Label Study of Azetukalner in Major Depressive Disorder
Active, not recruiting
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Active, not recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression3 recruiting
- Insomnia1 recruiting
Closed trials
Completed
A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Completed
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Completed
A Study to Test Different Doses of BI 1569912 in People With Depression
Completed
Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
Completed
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Completed
Completed
ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Completed
Completed
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026